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Ceramide is an integral part of the extracellular lipid bilayer of the stratum corneum (SC) that forms the permeability
barrier of the skin. The production of SC ceramides is catalyzed by sphingomyelinase (SMase) and
glucocerebrosidase (GCase). Acid-ceramidase (acid-CDase) catalyzes the hydrolysis of ceramide in the SC. We
examined the effects of T helper (Th)1 and Th2 cytokines on levels of transcripts of genes for acid-CDase, acid-
SMase, and GCase, on levels of ceramide, and on the extent of transepidermal water loss (TEWL) in the human
epidermis in an effort to determine whether these cytokines affect the permeability barrier functions. Levels of
transcripts for acid-SMase and GCase and the amount of ceramide in human epidermal sheets were enhanced by
tumor necrosis factor (TNF)-a and interferon (IFN)-c and these effects were inhibited in the presence of interleukin
(IL)-4. In epidermal keratinocytes cultured under submerged conditions, however, no similar inhibitory effects of IL-
4 were observed. Consistent with these results, TEWL was suppressed by TNF-a and IFN-c, and these effects were
also inhibited by IL-4. The balance between Th1 and Th2 might affect the construction and/or the repair of the
epidermal permeability barrier via regulation of the production of ceramide.
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Ceramide is an integral part of the extracellular lipid bilayer
of the stratum corneum (SC) that forms the permeability
barrier of the skin (Elias and Feingold, 1992). In the scaly
skin of patients with various inflammatory disorders, in par-
ticular, atopic dermatitis (AD), permeability barrier functions
are disrupted, with increases in transepidermal water loss
(TEWL) and decreases in levels of ceramide in the SC
(Imokawa et al, 1991; Motta et al, 1994; Di Nardo et al, 1998;
Tagami et al, 2001; Jensen et al, 2004), although it is unclear
whether there are any abnormalities in the permeability
barrier functions of the normal skin and non-active lesions
of such patients (Imokawa et al, 1991; Di Nardo et al, 1998;
Matsumoto et al, 1999; Sakurai et al, 2002).
It has been proposed that T helper (Th)2- and Th1-type
cells play a key pathogenic role in the acute phase and the
chronic phase, respectively, of AD (Grewe et al, 1998; Leung
et al, 2004). The association between immunopathological
features and cutaneous barrier functions, however, remains
to be clarified. Relationships between the effects of barrier
dysfunction and cutaneous inflammation have been dis-
cussed as follows. Di Nardo et al (1996) showed that cu-
taneous inflammatory reactions were enhanced in skin with
low levels of ceramide. Abnormal dryness is known to be
responsible for increased susceptibility to irritants and con-
sequent impairment of barrier functions (Tupker et al, 1990).
Nishijima et al (1997) showed that contact hypersensitivity
was more severely augmented in acutely barrier-disrupted
skin than in intact skin, not only as a result of increased
permeability but also as a result of activation of immune
reactivity. Kondo et al (1998) showed that, if percutaneous
sensitization is performed in barrier-disrupted skin, a Th2-
dominant reaction emerges in the afferent phase. By con-
trast, little information about the effects of cutaneous
inflammation on barrier dysfunction has been reported. In
particular, no studies of the relationship between the Th1/
Th2 balance and the regulation of barrier functions have
been reported to our knowledge.
In addition to being a major factor in both the permea-
bility barrier and the maintenance of the water reservoir of
the skin, ceramide, and/or its metabolites appear to be in-
volved in the proliferation, differentiation, and apoptosis of
epidermal keratinocytes (Wakita et al, 1994; Geilen et al,
1997). Moreover, Sallusto et al (1996) showed that ceramide
inhibits the uptake and presentation of antigens by dendritic
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cells in a murine model. It has also been proposed that
ceramide modulates cytokine signals, for example, in the
interleukin (IL)-1-mediated synthesis of prostaglandin and
the interferon (IFN)-g-induced expression of intercellular
adhesion molecule-1 and of human leukocyte antigen-DR
in keratinocytes (Ballou et al, 1992; Wakita et al, 1996;
Kirtikara et al, 1998). Taken together, various observations
suggest that the amount of ceramide in the epidermis might
modulate immunological responses in the skin. Therefore, it
seems to be appropriate to investigate the relationship be-
tween the production of ceramide and the balance between
Th1 and Th2 cytokines as part of the ongoing efforts to
elucidate the pathogenesis of various cutaneous disorders.
Skin ceramides are derived from newly synthesized
compounds and from the hydrolysis of glucosylceramides
and sphingomyelin (Holleran et al, 1993, 1994a; Jensen
et al, 1999). SC ceramides 2 and 5 are produced by the
hydrolysis of sphingomyelin by sphingomyelinase (SMase;
Uchida et al, 2000) and the other groups of SC ceramides
are produced by the degradation of glucosylceramide by
glucocerebrosidase (GCase; Hamanaka et al, 2002). Sev-
eral different forms of mammalian SMase have been iden-
tified (Schissel et al, 1996) and, in particular, acid-SMase is
associated with the synthesis of the extracellular ceramide
that acts as an intercellular lipid (Jensen et al, 1999). Both
acid-SMase and GCase are essential for homeostasis of the
permeability barrier (Holleran et al, 1994b; Jensen et al,
1999; Schmuth et al, 2000). Acid-ceramidase (acid-CDase),
but not alkaline-CDase, catalyzes the hydrolysis of cer-
amide to sphingosine and fatty acid in the SC under phys-
iological conditions (Yada et al, 1995; Arikawa et al, 2002;
He et al, 2003). It is well known that inflammatory cytokines,
such as tumor necrosis factor (TNF)-a and IL-1, and the
prototypic Th1 cytokine IFN-g stimulate the activity of
SMase and suppress the activity of CDase. The resultant
transient increase in levels of ceramide acts as a signal
transducer (Hannun, 1994). Moreover, enhancement of
SMase activity via the TNF-a receptor p55 is essential for
repair of the permeability barrier (Jensen et al, 1999). The
effects of these various agents on the levels of transcripts of
these enzymes, however, have not been elucidated.
In this study, we examined the effects of Th1 (IFN-g) and
Th2 (IL-4) cytokines on levels of transcripts for acid-CDase,
acid-SMase, and GCase, on the synthesis of ceramide in
the epidermis, and on the TEWL in an attempt to determine
whether the balance between Th1 and Th2 might affect the
production of ceramide and the permeability barrier func-
tions of the epidermis. Our results indicate that IL-4 might
act as an inhibitor of the construction and/or the repair of
the epidermal permeability barrier.
Results
Effects of Th1 and Th2 cytokines on the expression of
mRNA for acid-CDase, acid-SMase, and GCase in cul-
tured normal human epidermal keratinocytes (NHE-
K) As shown in Fig 1, levels of expression of mRNA for
acid-CDase in cultured NHEK fell upon stimulation of cells
by TNF-a and IFN-g. Levels of mRNA for acid-SMase and
GCase rose in response to TNF-a and IFN-g. These effects
of TNF-a and IFN-g on the levels of transcripts for acid-
CDase, acid-SMase, and GCase were unaffected by IL-4
(data not shown). Stimulation by IL-4 alone also did not
affect the levels of transcripts for acid-CDase, acid-SMase,
and GCase in cultured NHEK (data not shown). No effects
of IL-4 could be detected in this system, even when the
concentration of IL-4 was increased to 40 ng per mL.
Effects of Th1 and Th2 cytokines on the expression of
mRNA for acid-CDase, acid-SMase, and GCase in nor-
mal human epidermal sheets (NHESheets) Similar to
levels in cultured NHEK, levels of mRNA for acid-CDase,
acid-SMase, and GCase fell and rose upon stimulation by
Figure 1
Effects of tumor necrosis factor (TNF)-a and interferon (IFN)-c on levels of expression of mRNA for acid-ceramidase (acid-CDase), acid-
sphingomyelinase (acid-SMase), and glucocerebrosidase (GCase) in cultured normal human keratinocytes. Levels of mRNA for acid-CDase,
acid-SMase, and GCase in cultured normal human keratinocytes were examined by semiquantitative RT-PCR and normalized as described in
Materials and Methods. The duration of incubation of cells in the presence of TNF-a (10 ng per mL) and/or IFN-g (2 ng per mL) was 24 h. Data are
expressed as percentages relative to levels of mRNA in non-stimulated controls (C). Columns and bars show means  SEM; n¼ 10. p values refer to
the significance of differences from the non-stimulated controls (C).
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TNF-a and IFN-g, respectively, as shown in Fig 2. But in
NHESheets, as distinct from cultured NHEK, the enhancing
effects of TNF-a and IFN-g on the expression of mRNA for
acid-SMase and GCase were suppressed by IL-4. By con-
trast, IL-4 did not affect the suppressive effects of TNF-a
and IFN-g on the expression of the mRNA for acid-CDase.
Stimulation by IL-4 alone depressed the level of transcripts
for GCase in NHESheets and the effect was statistically
significant. Levels of mRNA for acid-SMase also tended to
be suppressed by IL-4 but the suppression was not statis-
tically significant (p¼0.106). Stimulation by IL-4 alone did
not affect levels of transcripts for acid-CDase.
Effects of Th1 and Th2 cytokines on total amounts of
ceramide in NHESheets harvested from organ cultures
of skin and living skin equivalent (LSE) Levels of cer-
amide in NHESheets obtained from normal human skin
barely changed in the absence of cytokine stimulation (data
not shown). As shown in Fig 3, however, they rose upon
stimulation by TNF-a and IFN-g. The effects of TNF-a and
IFN-g were suppressed by IL-4. The suppressive effects of
IL-4 were also evident in NHESheets obtained from LSE.
The amounts of ceramide in NHESheets were unaffected by
IL-4 alone (data not shown), and the amounts of ceramide in
cultured NHEK were unaffected by stimulation by TNF-a,
IFN-g, or IL-4 (data not shown).
Effects of Th1 and Th2 cytokines on TEWL in LSE The
extent of TEWL in LSE was reduced upon stimulation by
TNF-a and IFN-g, and the effects of TNF-a and IFN-g were
suppressed by IL-4, as shown in Fig 4.
Discussion
Stimulation by TNF-a and IFN-g depressed levels of the
transcripts for acid-CDase and enhanced those for acid-
SMase and GCase in cultured NHEK and NHESheets.
Moreover, the amount of ceramide in NHESheets obtained
from skin explants increased upon stimulation by TNF-a
and IFN-g, as compared with that obtained from non-stim-
ulated skin explants. These results suggest that Th1-pre-
dominant inflammation might be one of the factors that
Figure 2
Effects of tumor necrosis factor (TNF)-a, interferon (IFN)-c, and interleukin (IL)-4 on levels of expression of mRNA for acid-ceramidase
(acid-CDase), acid-sphingomyelinase (acid-SMase), and glucocerebrosidase (GCase) in normal human epidermal sheets. Levels of mRNA
for acid-CDase, acid-SMase, and GCase in cultured normal human epidermal sheet were examined by semiquantitative RT-PCR and normalized as
described in Materials and Methods. The duration of incubation in the presence of TNF-a (10 ng per mL), IFN-g (2 ng per mL), and/or IL-4 (20 ng per
mL) was 24 h. Data are expressed as percentages relative to levels of mRNA in non-stimulated controls (C). Columns and bars show means  SEM.
For (a)–(c), n¼ 4; for (d)–(f), n¼3.
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promote the production of ceramide in the epidermis, al-
though it remains to be determined whether the alterations
in levels of transcripts for these enzymes are correlated with
changes in the production of ceramide. In addition, other
ceramide-generating enzymes, such as serine palmitoyl
transferase, might affect the increase in the production of
ceramide (Holleran et al, 1991). The effects of TNF-a and
IFN-g, however, seem reasonable with respect to home-
ostasis of the permeability barrier, reflecting the enhanced
expression of GCase and acid-SMase after acute disruption
of this barrier (Holleran et al, 1994a, b; Jensen et al, 1999;
Schmuth et al, 2000). The involvement of Th1 cytokines in
the pathogenesis of AD (Grewe et al, 1998; Leung et al,
2004) suggests that our results support previous reports of
increases in the amount of acid-SMase (Kusuda et al, 1998)
and decreases in the activity of acid-CDase (Arikawa et al,
2002) in atopic lesional skin.
It was interesting to note that IL-4, a prototypic Th2
cytokine, suppressed the enhancing effects of TNF-a and
IFN-g on levels of transcripts for acid-SMase and GCase
and on the production of ceramide in epidermal sheets. The
mechanism of this effect of IL-4 remains unknown but our
results suggest that IL-4 might act as a suppressor of bar-
rier homeostasis and this suppressive effect of IL-4 might
be related to the decrease in ceramide in the SC in atopic
lesions. The impaired SMase activity in AD that was dem-
onstrated recently by Jensen et al (2004) supports this hy-
pothesis. It is unclear, however, whether the suppressive
effect of IL-4 on ceramide production, as demonstrated in
this study, is involved in the decrease in levels of ceramide
observed in the SC in cases of AD because (i) we did not
examine the effect of IL-4 on the activity of sphingomyelin
acylase, which appears to be a key enzyme in the decrease
in levels of ceramide in AD (Murata et al, 1996), and (ii) AD is
not always in the Th2-dominant state, as mentioned in the
Introduction.
It is unclear why the effects of IL-4 on levels of transcripts
of acid-SMase and GCase differed between cultured NHEK
and NHESheets. The difference might be related to differ-
entiation of keratinocytes and the differences in cellular fatty
acids (Terashi et al, 2000), which affect the regulation of
transcription (Jump, 2004).
The effects of TNF-a, IFN-g, and IL-4 on the amount
of ceramide in epidermal sheets were reproduced in
Figure 3
Effects of tumor necrosis factor (TNF)-a, interferon (IFN)-c, and interleukin (IL)-4 on total amounts of ceramide in normal human epidermal
sheets (NHESheets) harvested from organ cultures of skin and from living skin equivalents (LSE). Total amounts of ceramide in NHESheets (a,
b) harvested from organ cultures of skin and from LSE (c) were examined as described in Materials and Methods. The duration of incubation in the
presence of TNF-a (10 ng per mL), IFN-g (2 ng per mL), and/or IL-4 (20 ng per mL) was 72 h. Data are expressed as percentages relative to the total
amounts of ceramide in non-stimulated controls (C). Columns and bars show means  SEM. (a) NHESheets, n¼ 4; (b) NHESheets, n¼ 6; (c) LSE,
n¼6.
Figure 4
Effects of T helper (Th)1 and Th2 cytokines on transepidermal wa-
ter loss (TEWL) in living skin equivalents. The extent of TEWL in living
skin equivalents (LSE) was examined as described in Materials and
Methods. The duration of incubation in the presence of tumor necrosis
factor (TNF)-a (10 ng per mL), interferon (IFN)-g (2 ng per mL), and/or
interferon (IL)-4 (40 ng per mL) was 72 h. Data are expressed as per-
centages relative to the TEWL in non-stimulated controls (C). Columns
and bars show means  SEM; n¼11.
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experiments with LSE. This observation suggests that the
targets of the effects of TNF-a, IFN-g, and IL-4 in the reg-
ulation of ceramide levels in epidermal sheets were kera-
tinocytes because the epidermis of LSE consists of human
keratinocytes.
A particularly interesting result of this study was the de-
crease in TEWL in LSE upon stimulation by TNF-a and IFN-g
and the increase upon additional stimulation by IL-4. Since
ceramide is one of the important components of the per-
meability barrier of the skin, as mentioned above, the results
relating to TEWL are consistent with our results for levels of
ceramide and the two sets of results reinforce each other.
Moreover, this analysis of TEWL might explain the relation-
ship between the increased TEWL and allergic inflammation
in atopic skin, even though we did not examine the actual
effects of inflammation. This study seems, at least, to in-
dicate that a Th2 cytokine might act as an inhibitory factor
during the repair of a cutaneous barrier that has been dam-
aged by cutaneous inflammation. This hypothesis might be
compatible with the previous demonstration that distur-
bance of epidermal barrier functions can be induced by
patch test reactions to aeroallergens, which resemble les-
ional atopic eczema macroscopically, microscopically, and
immunopathologically, but not by patch test reactions to
contact allergens (Gfesser et al, 1996). But the effects of Th1
and Th2 cytokines on other important factors in the per-
meability barrier, for example, those involved in the secre-
tion of the contents of lamellar granules into the intercellular
domain, the formation of intercellular multilamellar lipid
sheets (Schwarzendruber et al, 1987; Fartasch et al, 1992;
Matsuki et al, 1998), and other epidermal lipids that are
important for permeability barrier function, such as choles-
terol and/or fatty acids (Wertz, 2000), remain unknown.
In conclusion, this study suggests that Th1 and Th2
cytokines might act in different ways to regulate the pro-
duction of ceramide that leads to barrier repair and/or
homeostasis. Further studies to determine directly the ef-
fects of Th1 and Th2 cytokines on barrier repair and/or
homeostasis are now necessary.
Materials and Methods
Culture of NHEK Normal human skin was obtained from fresh
surgically resected specimens in compliance with the Declaration
of Helsinki guidelines and after informed consent had been ob-
tained from each patient. Samples of skin were incubated with
phosphate-buffered saline (PBS) that contained 0.05% trypsin (DI-
FCO, Detroit, Michigan) and 0.02% EDTA overnight at room tem-
perature. After treatment with 0.05% trypsin inhibitor (Sigma, St
Louis, Missouri) for a few seconds, the epidermis was peeled away
from the dermis. A suspension of single cells was obtained by
vigorous pipetting. Cells were washed and cultured in keratinocyte
growth medium (KGM), which consisted of MCDB 153 medium
(Sigma), 0.09 mM CaCl2, 0.4 mg per mL hydrocortisone (Sigma),
5 mg per mL insulin (Eli Lilly Japan K.K., Kobe, Japan), 5 ng per mL
recombinant human (rh) epidermal growth factor (R&D Systems,
Minneapolis, Minnesota), and 50 mg per mL bovine pituitary ex-
tract (Biomedical Technologies Inc. Stoughton, MA, USA), at 371C
in a humidified atmosphere of 5% CO2 in air. Third- to fifth-pas-
sage cells were used for all experiments when they had reached
60%–70% confluence.
Culture of epidermal sheets Samples of normal human skin were
cut into disks (6 mm in diameter) with a punch. Epidermal sheets
were separated from each disk by treatment with 2000 IU per mL
dispase (Godo Shusei, Tokyo, Japan) for approximately 1 h at
371C. Epidermal sheets were floated in modified KGM that con-
sisted of MCDB 153 medium, 0.4 mg per mL hydrocortisone, 5 mg
per mL insulin, and an elevated concentration of CaCl2 (1.8 mM) to
prevent tissue degeneration (Tavakkol et al, 1999), at 371C in a
humidified atmosphere of 5% CO2 in air.
Organ culture of skin Disks of human skins, prepared as de-
scribed above, were cultured in modified KGM at 371C in a hu-
midified atmosphere of 5% CO2 in air. LSE (TESTSKIN-LSE high,
Toyobo, Osaka, Japan), which is a model of reconstructed skin,
was incubated in the same modified medium at 371C in a humid-
ified atmosphere of 5% CO2 in air. The surface of the epidermis
was kept under air-exposed conditions. The survival of organ cul-
tures was confirmed by a standard MTT assay, according to the
manufacturer’s protocol (Toyobo; data not shown).
Stimulation with cytokines NHEK, epidermal sheets, skin ex-
plants, and LSE were stimulated with 10 ng per mL rh TNF-a (In-
vitrogen, Carlsbad, California), 2 ng per mL rh IFN-g (Gibco BRL,
Gaithersburg, Maryland), and 20 or 40 ng per mL rh IL-4 (R&D
Systems). Incubation was continued for 24 h for NHEK and ep-
idermal sheets and for 72 h for skin explants and LSE.
Semiquantitative RT-PCR We examined the expression of mRNA
for acid-CDase, acid-SMase, and GCase in NHEK and epidermal
sheets after stimulation by cytokines by semiquantitative RT-PCR,
which was performed as described previously (Katagiri et al, 1997).
Fifty nanograms of RNA were reverse-transcribed using random
hexamers (Takara Shuzo, Shiga, Japan) and MMLV reverse tran-
scriptase (Gibco BRL). The resultant cDNA was amplified by PCR
in the presence of 1 mCi 32P-dCTP. We performed PCR for the
appropriate number of cycles (1 min at 941C; then 1 min at 571C
for acid-CDase, at 581C for glyceraldehyde-3-phosphate de-
hydrogenase (G3PDH), or at 601C for acid-SMase and GCase;
and 1 min at 721C) within the linear ranges of amplification as
follows: 20 cycles for G3PDH; 22 cycles for acid-CDase; and 24
cycles for acid-SMase and GCase. Aliquots (1 mL) of each sample
after amplification were analyzed by electrophoresis on a 5%
acrylamide/Tris-borate EDTA gel and products were visualized by
autoradiography. DNA was quantified by phosphor image analysis
(BAS2000; Fuji Medical Systems, Stanford, Connecticut). Levels of
mRNA for acid-CDase, acid-SMase, and GCase were normalized
by reference to levels of mRNA for G3PDH. The oligonucleotide
primers used for PCR were based on published sequences of
transcripts. The primers for amplification of cDNA for human
G3PDH were 50-CCCATCACCATCTTCCAG-30 for the upstream
primer and 50-CCTG CTTCA CCACCACCTTCT-30 for the down-
stream primer. For acid-CDase, we used 50-CCTTCTTCCTTGAT-
GATCGC-30 as the upstream primer and 50-GTGGAGTTCACCA
TGGTTCG-30 as the downstream primer; for acid-SMase, we used
50-TGGCTCTATGA AGCGATGG-30 as the upstream primer and 50-
AGGCCGATGTAGGTAGTTGC-30 as the downstream primer; and
for GCase we used 50-TGGCATTGCTGTACATTGG-30 as the up-
stream primer and 50-CGTTCT TCTGACTGGCAACC-30 as the
downstream primer. We identified the products of PCR by the fol-
lowing procedures. Each reaction mixture was subjected to elect-
rophoresis on an agarose gel and then bands of amplified
fragments were extracted and digested with an appropriate re-
striction endonuclease. The sizes of the products of PCR and of
the fragments were compared with the expected sizes by refer-
ence to mobilities of molecular size markers (100-bp ladder; Gibco
BRL).
Analysis of lipids After stimulation by cytokines, epidermal
sheets were collected from skin explants and LSE by treatment
with dispase. Lipids were extracted as described previously
(Terashi et al, 2000). The lipids in epidermal sheets were extract-
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ed with a mixture (1:2:1.5, vol/vol) of methanol, chloroform, and 0.1
M KCl in 50% methanol, and the organic phase was re-extracted
with 2.5 vol of 0.1 M KCl in 50% methanol. Precipitated proteins
were quantitated by a modified version of Lowry’s assay with bo-
vine serum albumin as the standard protein. The extracted fraction
was suspended in a mixture (1:1, vol/vol) of chloroform and meth-
anol after evaporation under a stream of nitrogen gas and was
applied to a thin-layer chromatography plate, as described by
Imokawa et al (1991). The plate was developed with a mixture
(190:9:1, vol/vol) of chloroform, methanol, and acetic acid. After
solvent development, the chromatogram was air-dried, sprayed
with an aqueous solution of 10% CuSO3 and 8% H3PO4, and
charred at 1801C. The charred lipids were quantitated by photo-
densitometry. Ceramides were quantitated by reference to appro-
priate commercial standards as follows: ceramide type III and
ceramide type IV (Sigma) were used as standards for ceramides 1
and 2 and for ceramides 3, 4, 5, and 6, respectively. The amounts
of ceramide were normalized by reference to amounts of protein
from the epidermal sheets.
Measurement of TEWL in LSE After incubation as mentioned
above, LSE was placed on a sponge that had been wetted with
PBS, with the dermal side facing the sponge. Approximately 30
min later, we measured TEWL with a ‘‘Tewameter’’ (TM300; Inte-
gral, Tokyo, Japan) at room temperature and ambient humidity.
Statistical analysis Results were compared, and the statistical
significance of differences was evaluated by Student’s t test. A
value of po0.05 was considered statistically significant.
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